Drugs for Aspergillosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 107)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Cathine |
Approved, Experimental, Illicit, Vet_approved, Withdrawn |
Phase 4 |
|
14838-15-4, 492-39-7 |
131954576 4786 26934 |
Synonyms:
(+-)-Norephedrine
(+)-Norpseudoephedrine
(+-)-Phenylpropanolamine
2-AMINO-1-PHENYLPROPAN-1-OL
Cathina
Cathine
Cathinum
D-Cathine
Dexatrim
DL-Norephedrine
DL-Phenylpropanolamine
D-Norephedrine
d-Norpseudoephedrine
d-Nor-psi-ephedrine
FENILPROPANOLAMINA
Hydriatine
Hydrochloride, phenylpropanolamine
Katine
L-NOREPHEDRINE
L-Phenyl propanolamine
|
Mucorama
Nobese
NOREPHEDRIN
Norephedrine
Obestat
PHENYLPROPANOLAMIN
Phenylpropanolamina
Phenylpropanolamine
PHÉNYLPROPANOLAMINE
Phenylpropanolamine hydrochloride
PHENYLPROPANOLAMINUM
PPA
Prestwick_388
Prolamine
Propadrine
Propagest
Pseudonorephedrine
psi-Norephedrine
Triaminic DM
Β-HYDROXYAMPHETAMINE
|
|
2 |
|
Guaifenesin |
Approved, Investigational, Vet_approved |
Phase 4 |
|
93-14-1 |
3516 |
Synonyms:
3-(2-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-1,2-propanediol
3-(O-Methoxyphenoxy)-propanediol-1,2
3-O-Methoxyphenoxypropane 1:2-diol
Actifed C
Aeronesin
a-Glyceryl guaiacol ether
a-Glyceryl guaiacolate ether
alpha-Glyceryl guaiacol ether
alpha-Glyceryl guaiacolate ether
Amonidren
Amonidrin
AMONIDRON
Aresol
Benylin-e
Breonesin
Bronchol
CVT-2534
Ether, guaiacol glyceryl
FAMEL
FRANOLYN CHESTY
GECOLATE
Glycerin ether
Glycerin guaiacolate
Glycero-guaiacol ether
Glycerol a-(2-methoxyphenyl) ether
Glycerol a-(O-methoxyphenyl)ether
Glycerol a-guaiacyl ether
Glycerol a-guiacyl ether
Glycerol a-monoguaiacol ether
Glycerol guaiacolate
Glycerol mono(2-methoxyphenyl) ether
Glycerol-a-guajakolether
Glycerol-alpha-guajakolether
Glyceryl ether, guaiacol
Glyceryl guaiacol
Glyceryl guaiacol ether
Glyceryl guaiacolate
Glyceryl guaiacolate ether
Glyceryl guaiacyl ether
Glyceryl guaicolate
Glyceryl guiacolate
Glycerylguaiacol
|
Guaiacol glycerol ether
Guaiacol glyceryl ether
Guaiacolate, glycerol
Guaiacolglicerinetere
Guaiacuran
Guaiacurane
Guaiacyl glyceryl ether
Guaiamar
Guaianesin
Guaicol glycerine ether
Guaicol glyceryl ether
Guaifenesin
GUAIFENESIN OR GUAIPHENESIN
Guaifenesina
Guaifenesine
Guaiphenesin
Guaiphenesine
Guaiphenezine
Guaiphesin
Guiatuss
HUMABID
Humibid
Hustosil
Hytuss
LIQUFRUTA
Methoxypropanediol
Methphenoxydiol
Metossipropandiolo
MUCINEX
NIROLEX FOR CHESTY COUGH DECONGESTANT
NSC-62112
O-Methoxyphenyl glyceryl ether
Organidin NR
p-Cresyl acetate
Pneumomist
Propanosedyl
Reduton
Robitussin
Scott tussin
Scott-tussin
ScottTussin
TIXYLIX CHESTY COUGH
|
|
3 |
|
Posaconazole |
Approved, Investigational, Vet_approved |
Phase 4 |
|
171228-49-2 |
147912 |
Synonyms:
|
4 |
|
Isavuconazole |
Approved, Investigational |
Phase 4 |
|
241479-67-4 |
21937662 |
Synonyms:
isavuconazol
Isavuconazole
|
|
|
5 |
|
Itraconazole |
Approved, Investigational |
Phase 4 |
|
84625-61-6 |
55283 |
Synonyms:
ITC
ITCZ
Itraconazol
ITRACONAZOLE
Itraconazole janssen brand
Itraconazolum
ITRAZOLE
Itrizole
ITZ
Janssen brand OF itraconazole
Janssen cilag brand OF itraconazole
|
Janssen-cilag brand OF itraconazole
ONMEL
Oriconazole
Orungal
R-51211
SPORANOS
Sporanox
SPORANOX I.V.
SPORANOX-PULSE
TOLSURA
|
|
6 |
|
Omalizumab |
Approved, Investigational |
Phase 4 |
|
242138-07-4 |
|
Synonyms:
IG GAMMA-1 CHAIN C REGION
IGE025
IGE25
IGE25|olizumab|R03DX05|RG-3648|rhumab-E25|Xolair®
OLIZUMAB
|
OMALIZUMAB
RG-3648
RHUMAB-E25
XOLAIR
|
|
7 |
|
Anidulafungin |
Approved, Investigational |
Phase 4 |
|
166663-25-8 |
166548 |
Synonyms:
(4R,5R)-4,5-DIHYDROXY-N²-[[4''-(PENTYLOXY)-P-TERPHENYL-4-YL]CARBONYL]-L-ORNITHYL-L-THREONYL-TRANS-4-HYDROXY-L-PROLYL-(S)-4-HYDROXY-4(P-HYDROXYPHENYL)-L-THREONYL-L-THREONYL-(3S,4S)-3-HYDROXY-4-METHYL-L-PROLINE CYCLIC (6->1)-PEPTIDE
1-((4R,5R)-4,5-Dihydroxy-N2-((4''-(pentyloxy)(1,1':4',1''-terphenyl)-4-yl)carbonyl)-L-ornithine)-echinocandin b
ANIDULAFUNGIN
Anidulafungina
Anidulafungine
Anidulafunginum
D70013
|
ECALTA
Eraxis
LY303366
LY-303366
V-ECHINOCANDIN
VER002
VER-002
|
|
8 |
|
Chlorpheniramine, phenylpropanolamine drug combination |
|
Phase 4 |
|
|
|
9 |
|
Antitussive Agents |
|
Phase 4 |
|
|
|
10 |
|
Immunoglobulins, Intravenous |
|
Phase 4 |
|
|
|
11 |
|
Immunoglobulin E |
|
Phase 4 |
|
|
|
12 |
|
Anti-Allergic Agents |
|
Phase 4 |
|
|
|
13 |
|
Hydroxyitraconazole |
|
Phase 4 |
|
|
108222 |
Synonyms:
|
14 |
|
Budesonide |
Approved |
Phase 2, Phase 3 |
|
51333-22-3 |
5281004 40000 63006 |
Synonyms:
(11b,16a)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11Β,16α)-16,17-(butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
AIRCORT
Bidien
BUDEFLAM AQUANASE
BUDELIN NOVOLIZER
BUDENOFALK
Budeson
Budesónida
BUDESONIDE
Budesonide, (R)-isomer
Budesonide, (S)-isomer
Budicort
CORTIMENT
Cortivent
Desowen
DEXBUDESONIDE
DUORESP SPIROMAX
ENTOCORT
ENTOCORT CR
Entocort ec
Entocort®|Eohilia® (budesonide oral suspension)|Jorveza®|Pulmicort®|S-1320|Uceris®
Horacort
MAP0010
|
MAP-0010
Micronyl
Noex
ORTIKOS
PREFERID
PULMAXAN
Pulmicort
PULMICORT FLEXHALER
PULMICORT L.S.
Pulmicort Nebuamp
PULMICORT RESPULES
Pulmicort Turbuhaler
R01AD05
Rhinocort
RHINOCORT ALLERGY
RHINOCORT AQUA
RHINOCORT AQUA 64
Rhinocort Turbuhaler
Rhinosol
S-1320
Spirocort
SYMBICORT
Tridesilon
Uceris
|
|
15 |
|
Deoxycholic acid |
Approved |
Phase 2, Phase 3 |
|
83-44-3 |
222528 |
Synonyms:
(3a,5a,12a)-3,12-DIHYDROXYCHOLAN-24-Oate
(3a,5a,12a)-3,12-DIHYDROXYCHOLAN-24-Oic acid
(3a,5b,12a)-3,12-Dihydroxycholan-24-Oate
(3a,5b,12a)-3,12-Dihydroxycholan-24-Oic acid
(3alpha,5alpha,12alpha)-3,12-DIHYDROXYCHOLAN-24-Oate
(3ALPHA,5ALPHA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID
(3alpha,5beta,12alpha)-3,12-Dihydroxycholan-24-Oate
(3alpha,5beta,12alpha)-3,12-Dihydroxycholan-24-Oic acid
(3Α,5α,12α)-3,12-dihydroxycholan-24-Oate
(3Α,5α,12α)-3,12-dihydroxycholan-24-Oic acid
(3Α,5β,12α)-3,12-dihydroxycholan-24-Oate
(3Α,5β,12α)-3,12-dihydroxycholan-24-Oic acid
12beta-Isomer deoxycholic acid
3a,12a-Dihydroxy-5b-cholanate
3a,12a-Dihydroxy-5b-cholanic acid
3alpha,12alpha-Dihydroxy-5beta-cholanate
3alpha,12alpha-Dihydroxy-5beta-cholanic acid
3beta-Isomer deoxycholic acid
3Α,12α-dihydroxy-5β-cholanate
3Α,12α-dihydroxy-5β-cholanic acid
5alpha-Isomer deoxycholic acid
5b-Cholanic acid-3a,12a-diol
5b-Deoxycholate
5b-Deoxycholic acid
7a-Deoxycholate
7a-Deoxycholic acid
7alpha-Deoxycholate
7alpha-Deoxycholic acid
7-Deoxycholate
7-Deoxycholic acid
7Α-deoxycholate
7Α-deoxycholic acid
Acid, 5alpha-isomer deoxycholic
Acid, choleic
Acid, deoxycholic
Acid, desoxycholic
Acid, dihydroxycholanoic
|
Acid, lagodeoxycholic
ATX-101
ATX-101|DCA|deoxycholate
Choleic acid
Cholerebic
Cholorebic
Degalol
Deoxycholatate
Deoxycholate
Deoxy-cholate
Deoxycholate, sodium
Deoxycholatic acid
Deoxycholic acid
Deoxy-cholic acid
Deoxycholic acid, 12beta isomer
Deoxycholic acid, 12beta-isomer
Deoxycholic acid, 3beta isomer
Deoxycholic acid, 3beta-isomer
Deoxycholic acid, 5alpha isomer
Deoxycholic acid, 5alpha-isomer
Deoxycholic acid, disodium salt
Deoxycholic acid, magnesium (2:1) salt
Deoxycholic acid, monoammonium salt
Deoxycholic acid, monopotassium salt
Deoxycholic acid, monosodium salt
Deoxycholic acid, sodium salt, 12beta-isomer
Desoxycholate
Desoxycholic acid
Desoxycholsaeure
Desoxycholsäure
Dihydroxycholanoic acid
DWJ211
DWJ-211
KYBELLA
Lagodeoxycholic acid
NSC-8797
Sodium deoxycholate
|
|
16 |
|
Fluticasone |
Approved, Experimental |
Phase 2, Phase 3 |
|
90566-53-3 |
4659387 5311101 |
Synonyms:
ADVAIR
Advair®|Avamys®|Flovent HFA®|Veramyst®
FLOVENT HFA
Fluticason
|
Fluticasona
Fluticasone
Fluticasonum
VERAMYST
|
|
17 |
|
Iron |
Approved |
Phase 3 |
|
7439-89-6 |
29936 |
Synonyms:
Carbonyl iron
Eisen
Electrolytic iron
Fe
FE (III) ion
Fe(3+)
Fe(III)
fer
Ferric ion
Ferric iron
Ferrum
|
Ferrum metallicum
Hierro
Iron powder
Iron(3+)
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (fe(3+))
Iron, reduced
Reduced iron
|
|
18 |
|
Darbepoetin alfa |
Approved, Investigational |
Phase 3 |
|
209810-58-2 |
|
Synonyms:
ARANESP
ARANESP SURECLICK
Darbepoetin
DARBEPOETIN ALFA
Darbepoetin alfa,recombinant
Darbepoetina alfa
|
EPOETIN
ERYTHROPOIETIN PRECURSOR
KRN321
KRN-321
NESP
|
|
19 |
|
Midazolam |
Approved, Illicit |
Phase 2, Phase 3 |
|
59467-70-8 |
4192 |
Synonyms:
Buccolam
Buccolam®|Dormicum®|Nayzilam®|USL261 (nasal spray formulation)|Versed®
Dea no. 2884
Dormicum
Hydrochloride, midazolam
Maleate, midazolam
Mezolam
Midazolam
Midazolam base
MIDAZOLAM CIV
|
Midazolam Hcl
Midazolam hydrochloride
Midazolam maleate
Midazolamum
Midazolamum [INN-Latin]
Nayzilam
USL261
USL-261
Versed
|
|
20 |
|
Ibrexafungerp |
Approved, Investigational |
Phase 3 |
|
1207753-03-4 |
75163792 |
Synonyms:
|
21 |
|
Caspofungin |
Approved |
Phase 3 |
|
179463-17-3, 162808-62-0 |
2826718 |
Synonyms:
(4R,5S)-5-((2-AMINOETHYL)AMINO)-N(2)-(10,12-DIMETHYLTETRADECANOYL)-4-HYDROXY-L-ORNITHYL-L-THREONYL-TRANS-4-HYDROXY-L-PROLYL-(S)-4-HYDROXY-4-(P-HYDROXYPHENYL)-L-THREONYL-THREO-3-HYDROXY-L-ORNITHYL-TRANS-3-HYDROXY-L-PROLINE CYCLIC (6-1)-PEPTIDE
(4R,5S)-5-((2-Aminoethyl)amino)-N(sup 2)-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (6-1)-peptide
(4R,5S)-5-((2-Aminoethyl)amino)-N2-(10,12-dimethyltetradecanoyl)-4-hydroxy-L-ornithyl-L-threonyl-trans-4-hydroxy-L-prolyl-(S)-4-hydroxy-4-(p-hydroxyphenyl)-L-threonyl-threo-3-hydroxy-L-ornithyl-trans-3-hydroxy-L-proline cyclic (1->6) disulfide
1-[(4R,5S)-5-[(2-AMINOETHYL)AMINO]-N(2)-(10,12-DIMETHYL-1-OXOTETRADECYL)-4-HYDROXY-L-ORNITHINE]-5-[(3R)-3-HYDROXY-L-ORNITHINE]-PNEUMOCANDIN B0
Cancidas
Capsofungin
Caspofungin
|
Caspofungin acetate
Caspofungin MSD
Caspofungina
L-743,872
L-743872
MK-991
N-[(3S,6S,9S,11R,15S,20R,21S,24S,25S)-3-[(1R)-3-Amino-1-hydroxypropyl]-21-[(2-aminoethyl)amino]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-5,8,11,17,20,23,25-heptahydroxy-15-[(1R)-1-hydroxyethyl]-2,14-dioxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0⁹,¹³]heptacosa-4,7,16,22-tetraen-18-yl]-10,12-dimethyltetradecanimidate
|
|
22 |
|
Deflazacort |
Approved, Investigational |
Phase 2, Phase 3 |
|
14484-47-0 |
26709 189821 |
Synonyms:
2-{11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.0,.0,.0,]icosa-6,14,17-trien-8-yl}-2-oxoethyl acetic acid
CALCORT
DEFLAZACORT
EMFLAZA
|
|
|
23 |
|
Fluconazole |
Approved, Investigational |
Phase 3 |
|
86386-73-4 |
3365 |
Synonyms:
2-(2,4-DIFLUOROPHENYL)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol
2,4-Difluoro-a,a-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
2,4-Difluoro-alpha,alpha-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
2,4-Difluoro-α,α-bis(1H-1,2,4-triazol-1-ylmethyl)benzyl alcohol
AbZ brand OF fluconazole
Aliud brand OF fluconazole
Alpharma brand OF fluconazole
Apo fluconazole
Apo-fluconazole
Apotex brand OF fluconazole
Armstrong brand OF fluconazole
Béagyne
Betapharm brand OF fluconazole
Biozole
CANESTEN ORAL
Chemia brand OF fluconazole
CT Arzneimittel brand OF fluconazole
CT-Arzneimittel brand OF fluconazole
Diflucan
DIFLUCAN IN SODIUM CHLORIDE
DIFLUCAN ONE
Difluconazole
Effik brand OF fluconazole
Elazor
Fluc hexal
Flucobeta
FlucoLich
Fluconazol
Fluconazol abz
Fluconazol al
Fluconazol isis
|
Fluconazol ratiopharm
Fluconazol stada
Fluconazol von CT
Fluconazole
Fluconazole capsules
FLUCONAZOLE IN SODIUM CHLORIDE
Fluconazol-isis
Fluconazol-ratiopharm
Fluconazolum
Flunazul
Fungata
Hexal brand OF fluconazole
Lavisa
Lesvi brand OF fluconazole
Lichtenstein brand OF fluconazole
Loitin
Mack brand OF fluconazole
Neofomiral
Oxifungol
Pfizer brand OF fluconazole
Pfleger brand OF fluconazole
Ratiopharm brand OF fluconazole
SAT brand OF fluconazole
Silanes brand OF fluconazole
Solacap
Stada brand OF fluconazole
Triflucan
UK-49858
Vita brand OF fluconazole
Zonal
|
|
24 |
|
Levoleucovorin |
Approved, Experimental, Investigational |
Phase 3 |
|
68538-85-2, 58-05-9, 73951-54-9 |
149436 6006 |
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R)-Leucovorin
(6R,2'S)-Folinic acid
(6R,S)-5-Formyltetrahydrofolate
(6S)-5-Formyl-5,6,7,8-tetrahydrofolate
(6S)-5-FORMYL-5,6,7,8-TETRAHYDROFOLIC ACID
(6S)-5-Formyltetrahydrofolate
(6S)-5-FORMYLTETRAHYDROFOLIC ACID
(6S)-Folinate
(6S)-FOLINIC ACID
(6S)-LEUCOVORIN
(S)-LEUCOVORIN
[6R]-5-formyl-5,6,7,8-tetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formlyl-5,6,7,8-tetrahydrofolate,calcium salt
5-Formyl-(6S)-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formylTHF
6 S Leucovorin
6R-Leucovorin
6S Leucovorin
6S-Leucovorin
6-S-Leucovorin
Acid, folinic
Acide folinique
Acido folinico
ácido levofolínico
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
CF
Citrovorum factor
Dextrofolinic acid
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
FUSILEV
KHAPZORY
|
Kunyrin
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucoverin
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, (S)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, (S)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monopotassium salt, (S)-isomer
Leucovorin, monosodium salt
Leucovorin, monosodium salt, (S)-isomer
Leucovorinum
Leukovorin
Leukovorum
Levo leucovorin
LEVOFOLENE
Levofolinate
LEVOFOLINIC ACID
Levoleucovorin
Levo-leucovorin
L-Folinate
L-FOLINIC ACID
LFP-754
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamate
N-[4-({[(6S)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID
N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
N5-Formyl-THF
Pteroyl-D-glutamate
Rescuvolin
S Leucovorin
S-Leucovorin
Welcovorin
Wellcovorin
|
|
25 |
|
Trimethoprim |
Approved, Vet_approved |
Phase 3 |
|
738-70-5 |
5578 |
Synonyms:
2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine
BW-5672
BW-56-72
CO-Trimoxazole
IPRAL
LEDATRIM
MONOTRIM
NIH-204
NSC-106568
POLYTRIM
PRIMSOL
Proloprim
PROLOPRIN
|
SYRAPRIM
TCMDC-125538
TIEMPE
TMP
TRIMETHOPRIM
TRIMETHOPRIME
TRIMÉTHOPRIME
TRIMETHOPRIMUM
TRIMETOPRIMA
TRIMOGAL
TRIMOPAN
Trimpex
TRIMPEX 200
TRIPRIMIX 200
|
|
26 |
|
Sulfamethoxazole |
Approved |
Phase 3 |
|
723-46-6 |
5329 |
Synonyms:
3-(p-Aminobenzenesulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulphonamido)-5-methylisoxazole
3-(Para-aminophenylsulphonamido)-5-methylisoxazole
3-Sulfanilamido-5-methylisoxazole
3-Sulphanilamido-5-methylisoxazole
4-Amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulphonamide
5-Methyl-3-sulfanilamidoisoxazole
5-Methyl-3-sulfanylamidoisoxazole
5-Methyl-3-sulfonylamidoisoxazole
5-Methyl-3-sulphanil-amidoisoxazole
ACETYLSULFAMETHOXAZOLE
Apo-Sulfamethoxazole
Azo Gantanol
Azo-gantanol
Bactrim
Bactrimel
Gamazole
Gantanol
GANTANOL (TN)
GANTANOL-DS
Metoxal
N'-(5-methyl-3-isoxazole)sulfanilamide
N'-(5-methyl-3-isoxazolyl)sulfanilamide
N'-(5-methyl-3-isoxazolyl)-sulfanilamide
N'-(5-methylisoxazol-3-yl)sulphanilamide
N^1-(5-methyl-3-isoxazolyl)-sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)-sulfanilamide
|
N1-(5-Methyl-3-isoxazolyl)sulphanilamide
Ndimethyl1-(5-methyl-3-isoxazolyl)-sulfanilamide
NSC-147832
Radonil
RO-42130
RO-4-2130
Septran
SIM
Simsinomin
Sinomin
SMX
SMZ
STX-608
Sulfamethalazole
Sulfamethoxazol
SULFAMETHOXAZOLE
SULFAMETHOXAZOLE SODIUM
Sulfamethoxazole(usan)
Sulfamethoxizole
Sulfamethylisoxazole
Sulfametoxazol
Sulfisomezole
Sulphamethalazole
Sulphamethoxazol
Sulphamethoxazole
Sulphamethoxazole BP 98
Sulpha-methoxizole
Sulphamethylisoxazole
Sulphisomezole
SUPHAMETHOXAZOLE
Trib
UROBAK
|
|
27 |
|
Cholecalciferol |
Approved, Nutraceutical, Vet_approved |
Phase 2, Phase 3 |
|
67-97-0, 1406-16-2 |
5280795 10883523 |
Synonyms:
(+)-Vitamin D3
(1S,3Z)-3-[(2E)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(1R)-1,5-DIMETHYLHEXYL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-1-CYCLOHEXANOL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-1-[(1R)-1,5-DIMETHYLHEXYL]-7A-METHYL-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENECYCLOHEXAN-1-OL
(1S,3Z)-3-[(2E)-2-[(1R,3AS,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL
(1S,3Z)-3-{2-[(1R,4E,7AR)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-OCTAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE}-4-METHYLIDENECYCLOHEXAN-1-OL
(3 beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3b,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3BETA,Z,7E)-9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-OL
(3Β,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-SECOCHOLESTA-5,7,10-TRIEN-3-OL
(5Z,7E)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
3-BETA,Z,7E-9,10-SECOCHOLESTR-5,7,10(19)-TRIEN-3-OL
7-DEHYDROCHOLESTEROL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3BETA-OL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-BETA-OL
9,10-SECOCHOLESTA-5,7,10(19)-TRIEN-3-OL
9,10-SECOCHOLESTA-5,7,10-TRIEN-3-OL
ACCRETE D3
ACIFEROL D3
ACTIVATED
Activated 7-dehydrocholesterol
ADCAL-D3
ARACHITOL
AVITICOL
BIOLIFE VITAMIN D3
BIO-VITAMIN D3
CACIT D3
CALCEOS
CALCICHEW D3
CALCICHEW D3 FTE
CALCICHEW D3 ONCE DAILY
CALCI-D
Calciferol
Calciol
CALDRINK D3
CALFOVIT D3
CC
Cholecalciferol
CHOLECALCIFEROL D3
Cholecalciferols
Cholecalciferolum
COLECAL D3
Colecalciferol
Colecalciferolum
COLEKAL-D3
COLEVIT D3
CUBICOLE D3
D3 LEMON MELTS
D3-50
D3-VIGANTOL
DEKRISTOL
DELSTEROL
Delta-D
DEPARAL
DESUNIN
DEVARON
Dihydrocholesterol
DLUX 400
D-MAX
D-TRACETTEN
|
D-VIT3
EBIVIT
E-D3
EVACAL D3
FERACOL
FULTIUM DAILY D3
FULTIUM-D3
GRANUVIT D3
HUX D3
INVITA D3
ISO D3
KORA LIQUID
MICRO-DEE
NATECAL D3
NATURE'S REMEDY VITAMIN D3
NEO-D
NPHD3
NSC-375571
Oleovitamin D3
OSTEOCAPS D3
PLENACHOL
PRO D3
PRO D3 FOLIC
PRO D3 FORTE
PROVITINA
QUINTOX
RICKETON
ROYALVIT D3
STEXEROL-D3
STIVIT-D3
SUNVIT-D3 1,000
SUNVIT-D3 10,000
SUNVIT-D3 2,000
SUNVIT-D3 20,000
SUNVIT-D3 3,000
SUNVIT-D3 400
SUNVIT-D3 5,000
SUNVIT-D3 50,000
SUNVIT-D3 800
SYNERVIT-D3
THEICAL D-3
THORENS
TRIVITAN
VIDDE-3-HYDROSOL
VI-DE3
VIDEKHOL
VIGANTOL
VIGANTOLETTEN
VIGANTOLETTEN 500
VIGORSAN
VIT D3 STREULI
VITA-D3
VITAMIN D
Vitamin D 3
VITAMIN D ASSAY SYSTEM SUITABILITY
Vitamin D NOS
Vitamin D, unspecified form
Vitamin D3
Vitamin D-3
VITINC DAN-DEE-3
ZYMAD
δ-D
|
|
28 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 3 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)FORMAMIDO]PENTANEDIOIC ACID
(2S)-2-[[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]-OXO-METHYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]GLUTARIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID
[<sup>3</sup>H]-folic acid
Acide folique
ácido fólico
Acidum folicum
ACIFOLIC
Apo-Folic
B03BB01
b9, Vitamin
BIO SCIENCE
CYTOFOL
DOSFOLAT B ACTIV
FOLACID
FOLACIN
FOLATE
FOLBAL
FOLCIDIN
FOLDINE
FOLETTES
FOLIAMIN
FOLIC ACID
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
FOLICARE
FOLICET
FOLIPAC
|
FOLSAEURE
FOLSAN
FOLSAURE
Folsäure
FOLSAV
FOLVITE
Folvron
INCAFOLIC
LEXPEC
LIVER LACTOBACILLUS CASEI FACTOR
MILLAFOL
N-(4-{[(2-AMINO-4-OXO-3,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)-L-GLUTAMIC ACID
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)CARBONYL]-L-GLUTAMIC ACID
N-[4-[[(2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL]AMINO]BENZOYL]-L-GLUTAMIC ACID
NATUR FLOW
N-Pteroyl-L-glutamate
N-PTEROYL-L-GLUTAMIC ACID
NSC-3073
PGA
PRECONCEIVE
PTEGLU
PTEROYLGLUTAMATE
PTEROYLGLUTAMIC ACID
PTEROYL-L-GLUTAMATE
PTEROYL-L-GLUTAMIC ACID
PTEROYL-L-MONOGLUTAMATE
PTEROYL-L-MONOGLUTAMIC ACID
PTEROYLMONOGLUTAMIC ACID
ROCHE
Vitamin B9
VITAMIN BC
VITAMIN BE
VITAMIN M
|
|
29 |
|
Rezafungin |
Investigational |
Phase 3 |
|
1396640-59-7 |
|
Synonyms:
|
Rezafungin cation
Rezafungin ion
|
|
30 |
|
Hemostatics |
|
Phase 2, Phase 3 |
|
|
|
31 |
|
Amphotericin B, deoxycholate drug combination |
|
Phase 2, Phase 3 |
|
|
|
32 |
|
Formoterol Fumarate |
|
Phase 2, Phase 3 |
|
|
|
33 |
|
Xhance |
|
Phase 2, Phase 3 |
|
|
|
34 |
|
Vitamins |
|
Phase 2, Phase 3 |
|
|
|
35 |
|
Trace Elements |
|
Phase 2, Phase 3 |
|
|
|
36 |
|
Calciferol |
|
Phase 2, Phase 3 |
|
|
|
37 |
|
Micronutrients |
|
Phase 2, Phase 3 |
|
|
|
38 |
|
Epoetin Alfa |
|
Phase 3 |
|
|
|
Synonyms:
BINOCRIT
EPO
EPOETIN ALFA
EPOGEN
|
EPREX
ERYTHROPOIETIN PRECURSOR
PROCRIT
|
|
39 |
|
Chrysarobin |
|
Phase 3 |
|
|
|
40 |
|
Amebicides |
|
Phase 3 |
|
|
|
41 |
|
Echinocandins |
|
Phase 3 |
|
|
|
42 |
|
Folic Acid Antagonists |
|
Phase 3 |
|
|
|
43 |
|
Folate |
|
Phase 3 |
|
|
|
44 |
|
Vitamin B9 |
|
Phase 3 |
|
|
|
45 |
|
Vitamin B Complex |
|
Phase 3 |
|
|
|
46 |
|
Antimalarials |
|
Phase 3 |
|
|
|
47 |
|
Trimethoprim, Sulfamethoxazole Drug Combination |
|
Phase 3 |
|
|
|
48 |
|
Amphotericin B |
Approved, Investigational |
Phase 2 |
|
1397-89-3 |
5280965 |
Synonyms:
ABBR amb
ABELCET
Ambisome
Amfotericina b
AMOPHOTERICIN B
AMPH-b
Amphocil
AMPHO-MORONAL
Amphortericin b
Amphotec
AMPHOTERCIN B
Amphotericin
AMPHOTERICIN B
Amphotericin b cholesterol dispersion
Amphotericin b colloidal dispersion
|
AMPHOTERICIN B LIPID COMPLEX
AMPHOTERICIN B LIPOSOMAL COMPLEX
Amphotericine b
AMPHOTÉRICINE B
Amphotericinum b
AMPHOTERICITIN B
AMPHOTREICIN B
AMPOTERICIN B
APT370
C-AMB
FUNGILIN
FUNGILIN IN ORABASE
Fungizone
Liposomal amphotericin b
NSC-527017
|
|
49 |
|
Nitric Oxide |
Approved |
Phase 2 |
|
10102-43-9 |
145068 |
Synonyms:
(.)NO
(NO)(.)
[NO]
EDRF
Endogenous nitrate vasodilator
Endothelium-derived nitric oxide
Endothelium-derived relaxing factor
HYDROXYAMINE
INOmax
INOmax®|nitric oxide|nitrogen monoxide
Mononitrogen monoxide
Monoxide, mononitrogen
Monoxide, nitrogen
Monoxido de nitrogeno
Monóxido de nitrógeno
Monoxyde d'azote
Nitrate vasodilator, endogenous
NITRIC OXIDE
Nitric oxide, endothelium derived
Nitric oxide, endothelium-derived
Nitrogen monooxide
|
Nitrogen monoxide
Nitrogen oxide
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl radical
Nitroxide radical
Nitroxyl
NO
NO(.)
OHM-11771
Oxide, nitric
Oxido de nitrogeno(II)
óxido de nitrógeno(II)
Oxido nitrico
óxido nítrico
Oxyde azotique
Oxyde nitrique
Stickstoff(II)-oxid
Stickstoffmonoxid
Vasodilator, endogenous nitrate
|
|
50 |
|
Olorofim |
Investigational |
Phase 2 |
|
1928707-56-5 |
|
Synonyms:
|
Interventional clinical trials:
(show top 50)
(show all 211)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation |
Unknown status |
NCT00986713 |
Phase 4 |
Amphotericin B |
2 |
Efficacy and Safety of Voriconazole for Treatment of Invasive Pulmonary Aspergillosis Secondary to COPD: a Multi-center Prospective,Open Cohort Study (VIA-COPD) |
Unknown status |
NCT02234739 |
Phase 4 |
Voriconazole |
3 |
Prospective, Open-label Study of the Efficacy and Safety of Caspofungin for the Treatment of Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease |
Unknown status |
NCT01499433 |
Phase 4 |
caspofungin |
4 |
A RANDOMIZED CONTROLLED STUDY OF ITRACONAZOLE IN CHRONIC CAVITARY PULMONARY ASPERGILLOSIS |
Completed |
NCT01259336 |
Phase 4 |
Itraconazole;treatment in cavitary pulmonary aspergillosis |
5 |
A Phase iv, Interventional, Non-blinded, Randomized Controlled Multicenter Study of Posaconazole Prophylaxis for the Prevention of Influenza-associated Aspergillosis (IAA) in Critically Ill Patients |
Completed |
NCT03378479 |
Phase 4 |
SOC +Posaconazole 18 MG/ML (milligram/milliliter) |
6 |
AmBisome® in Combination With Caspofungin Versus AmBisome® High Dose Regimen for the Treatment of Invasive Aspergillosis in Immunocompromized Patients: Randomized Pilot Study. |
Completed |
NCT00334412 |
Phase 4 |
Ambisome;caspofungin |
7 |
An Open Label, Non-comparative, Multicenter Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infection |
Completed |
NCT00647907 |
Phase 4 |
Voriconazole |
8 |
A Randomized Controlled Trial of the Effect of Cytochrome P450 2C19 Genotype-Specific Dosing Plus TDM vs. TDM Alone on Reaching Therapeutic Voriconazole Blood Levels |
Completed |
NCT03731169 |
Phase 4 |
Standard of Care |
9 |
A Phase 4, Open Label Study To Assess The Bronchopulmonary Pharmacokinetics Of Anidulafungin And Voriconazole Following Intravenous Administration In Healthy Subjects |
Completed |
NCT00940017 |
Phase 4 |
anidulafungin and voriconazole |
10 |
Treatment of Aspergillus Fumigatus in Patients With Cystic Fibrosis: A Randomized, Double-blind, Placebo-Controlled Trial |
Completed |
NCT00528190 |
Phase 4 |
Itraconazole |
11 |
Randomized and Multicenter Clinical Trial to Evaluate the Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy in Patients With Risk of Aspergillosis |
Recruiting |
NCT04238884 |
Phase 4 |
Voriconazole preemptive genotyping strategy;Voriconazole clinical practice |
12 |
Pharmacokinetics Study of Posaconazole in Haematology Patients Receiving Standard of Care Treatment With Oral Posaconazole Prophylaxis for Invasive Fungal Infection |
Recruiting |
NCT03717623 |
Phase 4 |
Posaconazole pharmacokinetics |
13 |
A SINGLE ARM, PROSPECTIVE, MULTI-CENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF ISAVUCONAZOLE FOR PRIMARY TREATMENT OF CHINESE PATIENTS WITH INVASIVE FUNGAL DISEASE (IFD) CAUSED BY ASPERGILLUS SPECIES OR OTHER FILAMENTOUS FUNGI |
Not yet recruiting |
NCT05630976 |
Phase 4 |
Isavuconazole |
14 |
An Exploratory, Randomized, Double-blind, Placebo Controlled Study to Assess the Efficacy of Multiple Doses of Omalizumab in Cystic Fibrosis Complicated by Allergic Bronchopulmonary Aspergillosis (ABPA) |
Terminated |
NCT00787917 |
Phase 4 |
Omalizumab;Placebo;Itraconazole |
15 |
A Multi-center, Open-label, Non-comparative Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Aspergillosis (CFDA Commitment) |
Terminated |
NCT02646774 |
Phase 4 |
Micafungin |
16 |
Phase IV Open-Label Pilot Study to Evaluate the Combination of Voriconazole and Anidulafungin for the Treatment of Subjects With Proven or Probable Invasive Aspergillosis Who Are Intolerant of Polyene Treatment |
Terminated |
NCT00620074 |
Phase 4 |
voriconazole;anidulafungin |
17 |
A Multi-center, Open-label, Non-comparative Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus Spp |
Terminated |
NCT02646800 |
Phase 4 |
Micafungin |
18 |
Phase IV, Single-Center, Open-Label Study Evaluating the Effects of an Anti-IL5 Receptor Alpha (Benralizumab) Monoclonal Antibody in the Treatment of Severe Asthma in Patients With Allergic Bronchopulmonary Aspergillosis |
Withdrawn |
NCT04108962 |
Phase 4 |
Fasenra, 30 Mg/mL Subcutaneous Solution |
19 |
A Double-Blind, Randomized Controlled Trial of Voriconazole (VFEND®) Plus Micafungin (MYCAMINE™) Versus Voriconazole Plus Placebo in the Treatment of Patients With Proven or Probable Invasive Aspergillosis |
Withdrawn |
NCT00423163 |
Phase 4 |
micafungin;voriconazole |
20 |
Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis. Open Label Phase III Clinical Study |
Unknown status |
NCT01125644 |
Phase 3 |
SPK-843 |
21 |
Efficacy of Intrabronchial Voriconazole Instillation for Inoperable Pulmonary Aspergilloma- a Randomized Controlled Trial |
Unknown status |
NCT03799809 |
Phase 2, Phase 3 |
Intrabronchial Voriconazole instillation |
22 |
A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis |
Completed |
NCT01857479 |
Phase 2, Phase 3 |
Inhaled budesonide;Inhaled amphotericin |
23 |
A Randomized Controlled Trial of Voriconazole in Allergic Bronchopulmonary Aspergillosis |
Completed |
NCT01621321 |
Phase 2, Phase 3 |
Prednisolone;Voriconazole |
24 |
A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma |
Completed |
NCT03133299 |
Phase 2, Phase 3 |
Glucocorticoids;Vitamin D |
25 |
Randomized Controlled Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis |
Completed |
NCT00974766 |
Phase 2, Phase 3 |
Glucocorticoids |
26 |
A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis |
Completed |
NCT02440009 |
Phase 2, Phase 3 |
Itraconazole;Glucocorticoids |
27 |
A Phase 3 Randomized Study of the Efficacy and Safety of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults and Adolescents (Phase 3; Protocol No. MK-5592-069) |
Completed |
NCT01782131 |
Phase 3 |
Posaconazole;Voriconazole;Placebo |
28 |
Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis |
Completed |
NCT01321827 |
Phase 2, Phase 3 |
Glucocorticoids;Itraconazole |
29 |
A Multicentre Randomised Controlled Trial Comparing the Current Standard Diagnostic Strategy for Invasive Aspergillosis to the New Diagnostic Strategy for Invasive Aspergillosis in High-Risk Haematology Patients in Order to Determine Which Strategy Results in the Lower Rates of Use of Empiric Antifungal Therapy |
Completed |
NCT00163722 |
Phase 3 |
|
30 |
A Randomized Controlled Trial to Compare the Clinical Outcomes of Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis |
Completed |
NCT03920527 |
Phase 3 |
Itraconazole 400 mg |
31 |
Voriconazole For Primary Therapy Of Proven, Chronic Bronchopulmonary Aspergillosis, In Minimally Immunocompromised Or, Non-Immunocompromised Hosts |
Completed |
NCT00159822 |
Phase 2, Phase 3 |
Voriconazole |
32 |
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch From Erythropoietin-stimulating Agents |
Completed |
NCT02879305 |
Phase 3 |
Daprodustat;rhEPO;Placebo;Iron therapy |
33 |
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi |
Completed |
NCT00634049 |
Phase 3 |
isavuconazole |
34 |
A Prospective, Randomized Trial Comparing The Efficacy Of Anidulafungin And Voriconazole In Combination To That Of Voriconazole Alone When Used For Primary Therapy Of Proven Or Probable Invasive Aspergillosis |
Completed |
NCT00531479 |
Phase 3 |
voriconazole;anidulafungin |
35 |
Study of the Safety and Efficacy of AmBisome Loading Dose Regimen Vs. a Standard AmBisome Regimen for Initial Treatment of Invasive Aspergillosis and Other Filamentous Fungal Infections in Immunocompromised Patients |
Completed |
NCT00158730 |
Phase 3 |
AmBisome |
36 |
An Open Label Non-Comparative Study of the Safety and Efficacy of Intravenous Anidulafungin Plus AmBisome® [(Amphotericin B) Liposome for Injection] as a Treatment for Invasive Aspergillosis. |
Completed |
NCT00037206 |
Phase 2, Phase 3 |
Anidulafungin, VER002 |
37 |
An Open Randomised Comparative Multicentre Study of the Efficacy, Safety and Toleration of Voriconazole Versus Amphotericin-B in the Treatment of Acute Invasive Aspergillosis in Immunocompromised Patients |
Completed |
NCT00003031 |
Phase 3 |
amphotericin B deoxycholate;voriconazole |
38 |
Nebulized Liposomal Amphotericin B (Ambisome) Versus Nebulized Placebo for the Prophylaxis of Invasive Pulmonary Aspergillosis in Haematological Patients With Prolonged Neutropenia. A Randomized Clinical Trial. |
Completed |
NCT00263315 |
Phase 2, Phase 3 |
nebulised liposomal amphotericin B |
39 |
Using Serum Galactomannan Levels in a Prospective, Randomised, Non-blinded Trial to Guide Early Anti-fungal Therapy in Haematology Patients at Risk of Invasive Aspergillosis. |
Completed |
NCT00361517 |
Phase 3 |
Amphotericin-B deoxycholate |
40 |
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis |
Completed |
NCT00001646 |
Phase 3 |
Voriconazole;Amphotericin B |
41 |
A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 Versus Voriconazole for Primary Treatment of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi. |
Completed |
NCT00412893 |
Phase 3 |
Isavuconazole;Voriconazole |
42 |
A Pharmacokinetic Study of JK1211 in Patients With Systemic Fungal Infection (SFI) and Patients With Febrile Neutropenia (FN) Suspected of Fungal Infection. |
Completed |
NCT00784368 |
Phase 3 |
ITCZ Oral Solution;ITCZ-IV |
43 |
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections |
Completed |
NCT00001810 |
Phase 3 |
Voriconazole |
44 |
A Phase III, Randomized, Double-Blind, Comparative Trial of FK463 Versus Fluconazole for Prophylaxis of Fungal Infections in Patients Undergoing a Hematopoetic Stem Cell Transplant |
Completed |
NCT00001937 |
Phase 3 |
FK463;Fluconazole |
45 |
A Randomized, Comparative, Open-label Study to Assess the Safety and Efficacy of MK-5592 Compared With Voriconazole in Japanese Subjects With Deep-seated Fungal Infection |
Completed |
NCT02180165 |
Phase 3 |
Posaconazole;Voriconazole |
46 |
A Multicenter, Double-Blind, Comparative Study of MK0991 (Caspofungin) Versus Micafungin in Adult Japanese Patients With Deep-seated Candida or Aspergillus Infections |
Completed |
NCT00717860 |
Phase 3 |
caspofungin acetate;Comparator: Micafungin sodium |
47 |
A Randomized, Comparative Study of Itraconazole Versus Fluconazole for Prevention of Aspergillus Infections in Peripheral Blood Stem Cell and Marrow Transplant Recipients |
Completed |
NCT00003883 |
Phase 3 |
fluconazole;itraconazole |
48 |
Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 (Ibrexafungerp) in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI) |
Recruiting |
NCT03059992 |
Phase 3 |
Ibrexafungerp |
49 |
A Randomized Controlled Trial of Deflazacort vs. Prednisolone in Acute-stage Allergic Bronchopulmonary Aspergillosis |
Recruiting |
NCT04227483 |
Phase 2, Phase 3 |
Deflazacort;Prednisolone |
50 |
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Allergic Bronchopulmonary Aspergillosis |
Recruiting |
NCT04442269 |
Phase 3 |
dupilumab;Placebo |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Caspofungin
Caspofungin acetate
Flucytosine
Itraconazole
|
Miconazole
Miconazole Nitrate
MICONAZOLE NITRATE PWDR
voriconazole
|
Cochrane evidence based reviews: aspergillosis
|